ProQR Therapeutics (PRQR) EBITDA (2013 - 2026)
ProQR Therapeutics (PRQR) posted EBITDA of -$9.43 million for the quarter ended Jun 30, 2026, compared with -$13.1 million a year earlier.
Powered by 
Analysis
ProQR Therapeutics (PRQR) EBITDA (2013 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA at ProQR Therapeutics was -$46.81 million; for the year ended Dec 31, 2025, it was -$46.03 million.
- In prior years, ProQR Therapeutics' EBITDA was -$29.99 million in the year ended Dec 31, 2024, -$31.74 million in the year ended Dec 31, 2023, -$66.02 million in the year ended Dec 31, 2022 and -$64.95 million in the year ended Dec 31, 2021.
- The figure for the quarter ended Jun 30, 2026 stands as the highest quarterly EBITDA since the quarter ended Sep 30, 2024.
- According to Business Quant data, EBITDA for the three prior quarters was -$15.17 million (quarter ended Mar 31, 2026), -$9.8 million (quarter ended Dec 31, 2025) and -$12.41 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 7.34 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 5.99 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 7.05 Bn |
| 10 | ProQR Therapeutics | 138.02 Mn | -322.63 Mn | - | -9.43 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -9.43 Mn |
| Mar 31, 2026 | -15.17 Mn |
| Dec 31, 2025 | -9.80 Mn |
| Sep 30, 2025 | -12.41 Mn |
| Jun 30, 2025 | -13.10 Mn |
| Mar 31, 2025 | -10.66 Mn |
| Dec 31, 2024 | -10.06 Mn |
| Sep 30, 2024 | -8.82 Mn |
| Jun 30, 2024 | -3.11 Mn |
| Mar 31, 2024 | -8.02 Mn |
| Dec 31, 2023 | -5.96 Mn |
| Sep 30, 2023 | -7.35 Mn |
| Jun 30, 2023 | -8.95 Mn |
| Mar 31, 2023 | -9.49 Mn |
| Dec 31, 2022 | -11.95 Mn |
| Sep 30, 2022 | -19.37 Mn |
| Jun 30, 2022 | -16.26 Mn |
| Mar 31, 2022 | -18.49 Mn |
| Dec 31, 2021 | -19.19 Mn |
| Sep 30, 2021 | -16.53 Mn |
API Access
ProQR Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=PRQR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "PRQR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=PRQR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();